Evidence map›Paper›PMID 39601592›Full record

ArticleJournal of virology2025

The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.

Masatoshi Kakizaki, Rina Hashimoto, Noriyo Nagata, Takuya Yamamoto, Takashi Okura, Hiroshi Katoh, Yuki Kitai, Yukiko Akahori, Kazuya Shirato, Akihide Ryo and 2 more

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Masatoshi KakizakiDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Rina HashimotoCenter for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Noriyo NagataDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0001-9147-1438
Takuya YamamotoCenter for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Takashi OkuraDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroshi KatohDepartment of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Yuki KitaiDepartment of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Yukiko AkahoriDepartment of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Kazuya ShiratoDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-3375-9799
Akihide RyoDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Kazuo TakayamaCenter for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.ORCID 0000-0002-1132-2457
Makoto TakedaDepartment of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-8194-7727

Funding

Astellas Foundation for Research on Metabolic DisordersJapan Agency for Medical Research and Development (AMED) JP21gm1610005Japan Agency for Medical Research and Development (AMED) JP23jf0126002Japan Agency for Medical Research and Development (AMED) JP243fa627001MEXT | Japan Society for the Promotion of Science (JSPS) 23K07935MEXT | Japan Society for the Promotion of Science (JSPS) 23K17416MEXT | Japan Society for the Promotion of Science (JSPS) JPJSCCA20240006Shionogi Infectious Disease Research Promotion FoundationThe Chemo-Sero-Therapeutic Research InstituteThe Mitsubishi Foundation
6 · The paper itself

Abstract

A critical aspect of the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the protease-mediated activation of the viral spike (S) protein. The type II transmembrane serine protease TMPRSS2 is crucial for SARS-CoV-2 infection in lung epithelial Calu-3 cells and murine airways. However, the importance of TMPRSS2 needs to be re-examined because the ability to utilize TMPRSS2 is significantly reduced in the Omicron variants that spread globally. For this purpose, replication profiles of SARS-CoV-2 were analyzed in human respiratory organoids. All tested viruses, including Omicron variants, replicated efficiently in these organoids. Notably, all SARS-CoV-2 strains retained replication ability in TMPRSS2-gene knockout (KO) respiratory organoids, suggesting that TMPRSS2 is not essential for SARS-CoV-2 infection in human respiratory tissues. However, TMPRSS2-gene knockout significantly reduces the inhibitory effect of nafamostat, indicating the advantage of TMPRSS2-utilizing ability for the SARS-CoV-2 infection in these organoids. Interestingly, Omicron variants regained the TMPRSS2-utilizing ability in recent subvariants. The basal infectivity would be supported mainly by cathepsins because the cathepsin inhibitor, EST, showed a significant inhibitory effect on infection with any SARS-CoV-2 strains, mainly when used with nafamostat. A supplementary contribution of other serine proteases was also suggested because the infection of the Delta variant was still inhibited partially by nafamostat in TMPRSS2 KO organoids. Thus, various proteases, including TMPRSS2, other serine proteases, and cathepsins, co-operatively contribute to SARS-CoV-2 infection significantly in the respiratory organoids. Thus, SARS-CoV-2 infection in the human respiratory tissues would be more complex than observed in cell lines or mice. IMPORTANCE: We explored how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus infects human respiratory organoids, which are a cultured cell model made to mimic the physiological conditions of the human airways. We focused on understanding the role of different proteases of host cells in activating the virus spike proteins. Specifically, we looked at TMPRSS2, a transmembrane serine protease, and cathepsin L, a lysosomal enzyme, which helps the virus enter cells by cutting the viral spike protein. We discovered that while TMPRSS2 is crucial for the virus in certain cells and animal models, other proteases, including cathepsins and various serine proteases, also play significant roles in the SARS-CoV-2 infection of human respiratory organoids. We suggest that SARS-CoV-2 uses a more complex mechanism involving multiple proteases to infect human airways, differing from what we see in conventional cell lines or animal models. This complexity might help explain how different variants can spread and infect people effectively.

Indexed as

Cathepsin LCathepsinsCOVID-19OrganoidsSARS-CoV-2Serine EndopeptidasesAnimalsBenzamidinesGene Knockout TechniquesGuanidinesHumansLungSpike Glycoprotein, CoronavirusVirus ReplicationBenzamidinesCathepsin LCathepsinsCTSL protein, humanGuanidinesnafamostatSerine EndopeptidasesSpike Glycoprotein, CoronavirusTMPRSS2 protein, humancathepsincleavageSARS-CoV-2TMPRSS2

Identifiers

PMID39601592
PMCPMC11784140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.